Article and Video CATEGORIES

Cancer Journey

Search By

Taofeek Owonikoko, MD, PhD, MSCR, is a Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A board-certified medical oncologist, Dr. Owonikoko specializes in the treatment of lung cancer, thyroid cancer and other cancers of the aerodigestive tract. He serves as Chair of the Lung and Aerodigestive Malignancies Working Group as well as Associate Director of the Hematology and Medical Oncology Fellowship Program in the Department of Hematology and Medical Oncology. Dr.

Lung Cancer Video Library - OWONIKOKO Treatment Options for Relapsed SCLC 2020 Update
dbrock
Lung Cancer Video Library - Treatment Options for Relapsed SCLC 2020 Update with Dr. Taofeek Owonikoko
Author
Taofeek Owonikoko, MD, PhD, MSCR, GRACE Faculty
Image
For this new addition to the GRACE Lung Cancer Video Library, Dr. Taofeek Owonikoko joins GRACE to discuss current updates in small cell lung cancer.

In this video, Dr. Owonikoko discusses updated information on treatment options for relapsed sclc.

 

To join the conversation, visit https://cancergrace.org/forum.

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

It is so good to hear from you!  And I am so happy to hear that your holidays have been good and that you are doing well.  It sounds like your...

Recent Comments

JOIN THE CONVERSATION
Biomarkers
By JanineT GRACE … on
Radiation Therapy
By JanineT GRACE … on
Oligometastatic vs Oligoprogression
By JanineT GRACE … on
Hi Stan!! and happiest of holidays!
By dbrock on